Moses Lake Pharmacy Recalls Methylcobalamin Injectable Solution Due to Sterility Concerns
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling Methylcobalamin Injectable Solution because the agency cannot assure the sterility of the compounded drug.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this recall as Class II. According to the severity rubric, an FDA Class II recall involving a drug with a sterility assurance issue is categorized as Severe (Score 4), as it may cause temporary or medically reversible adverse health consequences.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling Methylcobalamin Injectable Solution, 15 MG/ML, in various syringe sizes (5 mL, 6 mL, 10 mL, 15 mL, 20 mL, and 30 mL). The recall is being conducted because the U.S. Food and Drug Administration (FDA) cannot assure the sterility of the sterile human compounded drugs within their expiration dates.
The affected product is prescription-only (Rx only) and was distributed nationwide. The recall covers specific lots identified by codes ranging from t01052015 to 03312015. The total quantity involved includes 1 syringe of 5 mL, 1 syringe of 6 mL, 18 syringes of 10 mL, 1 syringe of 15 mL, 3 syringes of 20 mL, and 3 syringes of 30 mL.
Consumers and healthcare providers should stop using the recalled Methylcobalamin Injectable Solution and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- METHYLCOBALAMIN, Injectable Solution, 15 MG/ML, syringe sizes: 5 mL; 6 mL; 10 mL; 15 mL; 20 mL; 30 mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- t12312014@6
- t12042014@26
- t11252014@31
- t10302014@35
- t10282014@27
- t10242014@14
- t10032014@26
- t10012014@18
- t09302014@13
- t09222014@22
- t09172014@24
- t09052014@1
- t08132014@16
- t07302014@2
- t07222014@21
- t06302015@5
- t06182015@4
- t04102015@10
- t04062015@2
- t03062015@8
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- SevereSterling Recalls Carboxymethylcellulose Sodium Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereSterling Pharmaceutical Recalls Lubricating Tears Due to Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereWalgreens Lubricant Eye Drops Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2026-09-30
- SevereSodium Chloride Ophthalmic Solution Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePharm D Solutions Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- Severe
- SevereWells Pharmacy Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereMethylcobalamin Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-03-23
- SevereRXQ Compounding Recalls Methylcobalamin Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereMethylcobalamin Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23